Hannes Kettner
Research Specialist at UCSF and PhD Candidate at Imperial College London
Data updated
Research Footprint
Hannes Kettner appears in 40 tracked papers (2018–2026), most studied alongside Psilocybin, LSD and DMT, across Depressive Disorders, Anxiety Disorders and Set & Setting.
Most-cited paper: Predicting responses to psychedelics: a prospective study (418 citations).
Frequent co-authors: Robin Carhart-Harris, David Erritzoe and Leor Roseman.
Publication Landscape
How the 40 papers Blossom tracks for Hannes Kettner line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.
How has Hannes Kettner's publishing grown?
SourcedTracked papers by publication year. Click a year for the running total.
Don't read as total output: only the 40 of 40 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.
What does Hannes Kettner publish on?
SourcedTracked papers per topic. Orange marks the largest research focus.
Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Where does Hannes Kettner publish?
SourcedTracked papers per journal. Orange marks the most-used journal.
Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.
Background & Research
Hannes Kettner is a researcher specializing in the psychopharmacology of psychedelics, with a focus on environmental and psychosocial factors. His large-scale observational studies have been instrumental in defining how context influences the therapeutic and transformative potential of psychedelic sessions in both lab and naturalistic settings.
Key Impact
A leading expert in the observational study of 'set and setting' and its influence on the psychedelic experience.
Collaboration Network
52 collaborators· click a node to visit their profile
Full network →Collaboration Network
See Hannes Kettner's full collaboration network, shared papers, and research connections.
Compounds
Topics
Top Collaborators
Top Collaborators
Unlock clinical summaries, full texts, and related trial mapping.
Affiliations
Institutions, companies, and organisations Hannes Kettner is associated with.
Imperial College London
academicThe Centre for Psychedelic Research, led by Professor David Nutt and Dr. David Erritzoe, focuses heavily on the action of psychedelic drugs in the brain and their clinical utility as aides to psychotherapy. Thanks to their extensive neuroimaging studies, this group has proposed vital mechanisms for how psychedelics work, including the Entropic Brain Theory and REBUS (RElaxed Beliefs Under Psychedelics).
View stakeholder →Maastricht University
academicWhile Maastricht University may not have a single dedicated psychedelic research group, various researchers at the university are investigating the effects of psychedelics. Early research exploring psychedelics at Maastricht focused on the dangers of MDMA. Now, research into the effects of microdosing is being led by Dr Kim Kuypers. Other research ongoing at the university is investigating cannabis as well as novel psychoactive substances (NPS). Maastricht is collaborating on research with the Beckley Foundation as well as Silo Pharma.
View stakeholder →